Search Results - "Uroš Smrdel"

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers by Skoblar Vidmar, Marija, Doma, Andrej, Smrdel, Uroš, Zevnik, Katarina, Studen, Andrej

“…The evaluation of treatment response remains a challenge in glioma cases because the neuro oncological therapy can lead to the development of treatment-related…”
Get full text

Optimization of brain tumours irradiation determining the set-up margin by Zager-Marcius, Valerija, Dolenc, Laura, Smrdel, Uros

“…The aim of this work was to evaluate whether the excising margin of the clinical tumor volume and planning target volume correspond with calculated radiation…”
Get full text

Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas by Smrdel, Uroš, Škufca Smrdel, Andreja Cirila, Podlesek, Anja, Skoblar Vidmar, Marija, Kos, Gregor, Markovic, Jana, Jereb, Jana, Knific, Jana, Rus, Tina

“…To investigate the prognostic factors of survival in patients with high-grade gliomas without isocitrate dehydrogenase-1 (IDH) mutation and…”
Get full text

Glioblastoma in patients over 70 years of age by Smrdel, Uros, Vidmar, Marija Skoblar, Smrdel, Ales

“…Glioblastoma has in last 20 years seen the steady increase of incidence, which is most prominent in the group of older patients. These older than 70 years have…”
Get full text

Radiotherapy for benign disease by Ivica Ratoša, Blaž Grošelj, Boris Jančar, Uroš Smrdel, Jasna But Hadžić, Helena Barbara Zobec Logar

“…Radiation therapy for benign disease aims to restore function and can improve quality of life. Irradiation for benign conditions is usually performed with a…”
Get full text

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor by Smrdel, Uros, Popovic, Mara, Zwitter, Matjaz, Bostjancic, Emanuela, Zupan, Andrej, Kovac, Viljem, Glavac, Damjan, Bokal, Drago, Jerebic, Janja

“…In spite of significant improvement after multi-modality treatment, prognosis of most patients with glioblastoma remains poor. Standard clinical prognostic…”
Get full text

Cognitive functioning in a cohort of high-grade glioma patients by Skufca Smrdel, Andreja Cirila, Podlesek, Anja, Skoblar Vidmar, Marija, Markovic, Jana, Jereb, Jana, Okorn, Manja Kuzma, Smrdel, Uros

“…High grade gliomas are associated with cognitive problems. The aim of the study was to investigate cognitive functioning in a cohort of patients with high…”
Get full text

Evaluation of frailty, cognitive function, and age as prognostic factors for survival in patients with IDH1wild-type high-grade glioma by Škufca Smrdel, Andreja Cirila, Podlesek, Anja, Markovič, Jana, Jereb, Jana, Vidmar, Marija Skoblar, Smrdel, Uroš

“…Abstract INTRODUCTION: High-grade gliomas without isocitrate dehydrogenase (IDH) mutations are associated with poor survival and have been poorly studied. Our…”
Get full text

Stereotaktična radiokirurgija možganskih zasevkov malignega melanoma by Uroš Smrdel

“…Ni abstrakta…”
Get full text

Reccomendations for diagnosis and treatment of patients with malignant lymphoma by Barbara Jezeršek Novaković, Lučka Boltežar, Gordana Gašljevič, Biljana Grčar Kuzmanov, Monika Jagodic, Tanja Južnič Šetina, Veronika Kloboves-Prevodnik, Gregor Kos, Milica Miljković, Jana Pahole, Samo Rožman, Urška Rugelj, Marija Skoblar Vidmar, Uroš Smrdel, Daniela Štrbac, Miha Toplak, Lorna Zadravec Zaletel, Mateja Dolenc Voljč

Get full text

Obravnava bolnika z nizkomalignim gliomom by Uroš Smrdel, Tadej Strojnik

“…Ni abstrakta…”
Get full text

Cognitive functioning is prognostic in patients with IDHl-wild type and MGMT-unmethylated high-grade gliomas by Smrdel, Uros, Smrdel, Andreja Cirila Skufca, Podlesek, Anja, Vidmar, Marija Skoblar, Kos, Gregor, Markovic, Jana, Jereb, Jana, Knific, Jana, Rus, Tina

“…Aim To investigate the prognostic factors of survival in patients with high-grade gliomas without isocitrate dehydrogenase-1 (IDH) mutation and…”
Get full text

Smernice za obravnavo bolnikov z malignimi limfomi by Barbara Jezeršek Novaković, Gorana Gašljević, Monika Jagodic, Tanja Južnič Šetina, Jana Pahole Goličnik, Veronika Kloboves-Prevodnik, Marija Skoblar Vidmar, Uroš Smrdel, Danijela Štrbac, Lorna Zadravec-Zaletel

Get full text

Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial by Zwitter, Matjaz, Kovac, Viljem, Smrdel, Uros, Vrankar, Martina, Zadnik, Vesna

“…Gemcitabine in low dose in prolonged infusion is a treatment with documented activity against a variety of tumors. We here report the first randomized trial to…”
Get more information

Immunohistochemical and Genetic Markers in Glioblastoma Multiforme by Smrdel, Uros

“…Introduction: Glioblastoma (GBM) is the most common primary brain tumour. Incidence of GBM in Slovenia is 2.9 patients per 100.000 inhabitants. Mean overall…”
Get full text

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma by Kovac, Viljem, Zwitter, Matjaz, Rajer, Mirjana, Marin, Aleksander, Debeljak, Andrej, Smrdel, Uros, Vrankar, Martina

“…After a favorable experience with gemcitabine at a low dose in a prolonged infusion in combination with cisplatin for advanced non-small-cell lung cancer,…”
Get full text

Glioblastoma patients in Slovenia from 1997 to 2008 by Smrdel, Uros, Kovac, Viljem, Popovic, Mara, Zwitter, Matjaz

“…Background. Glioblastoma is the most common primary brain tumour. It has a poor prognosis despite some advances in treatment that have been achieved over the…”
Get full text

Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial by Zwitter, Matjaz, Kovac, Viljem, Rajer, Mirjana, Vrankar, Martina, Smrdel, Uros

“…We present experience from a phase II randomized clinical trial, comparing standard gemcitabine as monotherapy with low-dose gemcitabine in long infusion in a…”
Get full text

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung : A Phase II Clinical Trial by Kovac, Viljem, Zwitter, Matjaz, Smrdel, Uros, Vrankar, Martina, Kern, Izidor, Rajer, Mirjana

“…Background. Intermittent application of chemotherapy and tyrosine kinase inhibitors may avoid antagonism between the two classes of drugs. This hypothesis was…”
Get full text

Genetic markers in oligodendroglial tumours by Velnar, Tomaz, Smrdel, Uros, Popovic, Mara, Bunc, Gorazd

“…Oliogodendrogliomas are brain tumours composed of the cells resembling oligodendrocytes. They represent the third most common glial tumour, comprising 2.5% of…”
Get full text